17 results
8-K
EX-99.1
YBGJ
Yubo International Biotech Ltd
23 May 01
Current report
12:00am
by Magna-Lab under the scientific leadership of Dr. Minkoff. I
am very excited about the future of Magna-Lab as we enter this new phase
8-K
YBGJ
Yubo International Biotech Ltd
14 Jan 21
Entry into a Material Definitive Agreement
2:54pm
, anti-aging treatments, clinical transformation and other application fields. We believe our existing technology and leadership position in stem cell … of Directors, c/o Yubo International Biotech Limited, Room 105, Building 5, 31 Xishiku Avenue, Xicheng District, Beijing, PRC.
Board Leadership
10-KT
YBGJ
Yubo International Biotech Ltd
23 Apr 21
Annual report (with FYE transition)
5:05pm
Biotech Limited, Room 105, Building 5, 31 Xishiku Avenue, Xicheng District, Beijing, PRC.
Board Leadership Structure and Role on Risk Oversight
Mr … . Jun Wang currently serves as the Company’s principal executive officer and a director. The Company determined this leadership structure was appropriate
S-1
wve6l7tq7
6 May 21
IPO registration
6:03am
S-1/A
h5r2gl22 6j5
12 Jul 21
IPO registration (amended)
4:50pm
424B3
gk9c 8fdsji02aa
1 Aug 22
Prospectus supplement
6:04am
- Prev
- 1
- Next